Cargando...
THALIDOMIDE TREATMENT PREVENTS CHRONIC GRAFT REJECTION AFTER AORTIC TRANSPLANTATION IN RATS
BACKGROUND: Cardiac allograft vasculopathy (CAV) affects approximately 30% of cardiac transplant patients at five years post-transplantation. To date there are few CAV treatment or prevention options, none of which are highly effective. The aim of the study was to investigate the effect of thalidomi...
Guardado en:
| Publicado en: | Transpl Int |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5643223/ https://ncbi.nlm.nih.gov/pubmed/28672061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.13004 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|